USPSTF cervical cancer screening guidelines
This article was originally published in The Gray Sheet
Executive Summary
Evidence is insufficient to recommend "for or against" use of new screening technologies, including liquid-based cytology, as well as HPV DNA testing, as a primary screen, U.S. Preventive Services Task Force states in guidelines released Jan. 22. While sensitivity generally is increased for liquid-based cytology, more false-positives often result, making it "not clear whether the possible benefits, if any, would be large enough to justify the added costs." USPTF's recommendations on screening intervals and when to start and cease screening are in line with ACS guidelines released in December (1"The Gray Sheet" Jan. 6, 2002, p. 23)...